Detection of metastatic bone lesions in patients with prostate carcinoma:99Tc monoclonal antibody imaging

Basit Öğe Kaydı
dc.contributor.authorKıraç, S
dc.contributor.authorDuman, Yusuf
dc.contributor.authorCüreklibatır, İbrahim Kadri
dc.contributor.authorYüksel, Doğan Emre
dc.contributor.authorNazlı, Oktay
dc.contributor.authorGünaydın, Gürhan
dc.contributor.authorTaner, M
dc.date.accessioned2019-12-23T14:30:10Z
dc.date.available2019-12-23T14:30:10Z
dc.date.issued1997
dc.departmentEge Üniversitesien_US
dc.description.abstract…en_US
dc.identifier.endpage973en_US
dc.identifier.issue.en_US
dc.identifier.startpage968en_US
dc.identifier.urihttps://hdl.handle.net/11454/55787
dc.identifier.volume18en_US
dc.language.isoenen_US
dc.relation.journalNUCLEAR MEDICINE COMMUNICATIONSen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US]
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleDetection of metastatic bone lesions in patients with prostate carcinoma:99Tc monoclonal antibody imagingen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Öksüz Yayınlar